Outcomes of late endovascular recanalization for symptomatic non-acute atherosclerotic intracranial large artery occlusion

医学 四分位间距 闭塞 心脏病学 内科学 血管内治疗 外科 冲程(发动机) 动脉瘤 机械工程 工程类
作者
Yindan Yao,Ao-Fei Liu,Hancheng Qiu,Jingbo Zhou,Chen Li,Qi Wang,Jin Lv,Weijian Jiang
出处
期刊:Clinical Neurology and Neurosurgery [Elsevier BV]
卷期号:187: 105567-105567 被引量:18
标识
DOI:10.1016/j.clineuro.2019.105567
摘要

The optimal treatment of symptomatic non-acute atherosclerotic intracranial large artery occlusion (ILAO) beyond 24 h from onset remains uncertain. We investigate the outcomes of late endovascular recanalization for symptomatic non-acute atherosclerotic ILAO.From September 2013 to July 2018, with safety as the first principle, late endovascular recanalization for symptomatic non-acute atherosclerotic ILAO beyond 24 h from onset was attempted in 32 consecutive patients. Primary safety outcome was any stroke or death within 30 days. Primary efficacy outcome were functional independence at 90 days.The median time from imaging-documented occlusion to treatment was 25.5 days (interquartile range: 10.5-36.5) for all patients. Technical success in recanalization was achieved in 17 patients (53.1%, 17/32). The 30-day rate of any stroke or death was 5.9% (1/17) in the recanalized group versus 6.7% (1/15) in the failure group (P = 0.927). The rate of functional independence at 90 days (70.5%, 12/17) was increased significantly as compared with that before operation (23.5%, 4/17) in the recanalized group (P = 0.015). The rate of functional independence at 90 days (66.7%, 10/15) was not different from that before operation (66.7%,10/15) in the failure group (P = 1.00). The median score reduction in mRS from baseline at 90 days was 1.0 (interquartile range: 1.0-2.0) in the recanalized group versus 0 (interquartile range: 0.0-0.0) in the failure group (P<0.001).For carefully selected patients with symptomatic non-acute atherosclerotic ILAO beyond 24 h from onset, late endovascular recanalization is technically feasible. The periprocedural safety of late endovascular recanalization is acceptable. Successful recanalization may effectively improve the degree of disability in such patients. However, it should be emphasized that revascularization of non-acute ILAO is a high risk procedure, which should only be performed by experienced operators with safety as the first principle.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CipherSage应助开朗以亦采纳,获得10
刚刚
笨笨山芙应助夏洳采纳,获得10
刚刚
自由书易发布了新的文献求助10
1秒前
有朋自远方来完成签到,获得积分10
1秒前
xyz完成签到,获得积分10
1秒前
zwc发布了新的文献求助10
1秒前
闪闪梦山发布了新的文献求助10
1秒前
啦咯是吗发布了新的文献求助10
2秒前
HoaryZ完成签到,获得积分10
2秒前
3秒前
倪大业666完成签到 ,获得积分10
3秒前
初景发布了新的文献求助30
3秒前
烟花弥漫完成签到 ,获得积分10
4秒前
5秒前
6秒前
6秒前
shen完成签到,获得积分10
6秒前
小二郎应助平常寄柔采纳,获得10
6秒前
852应助李本来采纳,获得10
7秒前
菁菁完成签到,获得积分10
7秒前
8秒前
Akim应助李团团团成团采纳,获得30
8秒前
彭于晏应助闪闪梦山采纳,获得10
9秒前
lin666完成签到 ,获得积分10
9秒前
超帅水杯发布了新的文献求助10
9秒前
10秒前
菁菁发布了新的文献求助10
10秒前
pangpanghu完成签到,获得积分10
10秒前
盛夏如花发布了新的文献求助10
12秒前
科研通AI2S应助蓝天采纳,获得10
12秒前
Chao完成签到,获得积分10
12秒前
Kao应助滕皓轩采纳,获得10
13秒前
13秒前
不充Q币发布了新的文献求助10
13秒前
蓦然回首完成签到,获得积分10
14秒前
奋斗含巧完成签到,获得积分10
14秒前
娟娟SCI完成签到,获得积分10
14秒前
saylor发布了新的文献求助10
14秒前
solution完成签到 ,获得积分10
15秒前
kaka22发布了新的文献求助20
15秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Development of a Bridge Weigh-In-Motion System: A technology to convert the bridge response to the passage of traffic into data on vehicle configurations, speeds, times of travel and weights 1000
Current concepts in cutaneous toxicity : proceedings of the Fourth Conference on Cutaneous Toxicity, Washington, D.C., May 9-11, 1979 1000
ズームレンズの光学設計に関する研究 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7280112
求助须知:如何正确求助?哪些是违规求助? 8901189
关于积分的说明 18828206
捐赠科研通 6952161
什么是DOI,文献DOI怎么找? 3207313
关于科研通互助平台的介绍 2377610
邀请新用户注册赠送积分活动 2182320